{"schema_version":"1","generated_at":"2026-11-21T13:22:08.249Z","data_as_of":null,"url":"https://www.findmykol.com/kol/gregory-simpson","json_url":"https://www.findmykol.com/kol/gregory-simpson/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"gregory-simpson","name":"Gregory Simpson","credential":"MD","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Dermatology","therapeutic_areas":["Dermatology"],"institution":"University of California System","institution_url":"https://www.findmykol.com/institution/university-of-california-system","city":"Fresno","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Gregory Simpson is a Dermatology physician affiliated with University of California System. OpenAlex indexes 16 publications with 330 citations (h-index 6); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Dermatology"]},"scholarship":{"works_count":16,"cited_by_count":330,"h_index":6,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02756286","title":"Neurophysiological Attention Test (NAT) for Objective Assessment of Adult ADHD","status":"COMPLETED","role":"Overall official","sponsor":"Think Now Incorporated","source_url":"https://clinicaltrials.gov/study/NCT02756286","trial_url":"https://www.findmykol.com/trial/NCT02756286"},{"nct":"NCT02407496","title":"Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","role":"Overall official","sponsor":"Think Now Incorporated","source_url":"https://clinicaltrials.gov/study/NCT02407496","trial_url":"https://www.findmykol.com/trial/NCT02407496"}],"source":"trials"},"payments":{"company_count":11,"program_years":{"first":2021,"last":null},"rows_total":18,"shown":3,"withheld":15,"rows":[{"payer":"Janssen","program_year":2025,"amount_usd":51421.3,"payment_count":13},{"payer":"AbbVie","program_year":2025,"amount_usd":1720,"payment_count":1},{"payer":"Laborie Medical Technologies Corp.","program_year":2025,"amount_usd":46,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":7,"areas_shown":3,"areas":[{"area":"Dermatology","share_pct":37.1,"classes_total":5,"classes":[{"class":"Corticosteroid","setting":"mixed","share_pct":26.1,"drugs":[{"name":"Triamcinolone Acetonide","share_pct":50.5},{"name":"Triamcinolone acetonide","share_pct":45.2},{"name":"Halobetasol Propionate","share_pct":4.3}],"max_beneficiaries":null},{"class":"Interleukin-4 Receptor alpha Antagonist","setting":"prescribed","share_pct":7.1,"drugs":[{"name":"Dupixent Pen","share_pct":50},{"name":"Dupixent Syringe","share_pct":50}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":24.3,"classes_total":7,"classes":[{"class":"TNF inhibitor","setting":"prescribed","share_pct":6.3,"drugs":[{"name":"Humira(Cf) Pen","share_pct":82.2},{"name":"Humira(Cf)","share_pct":17.8}],"max_beneficiaries":null},{"class":"Folate Analog Metabolic Inhibitor","setting":"prescribed","share_pct":5.2,"drugs":[{"name":"Methotrexate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Anti-infectives","share_pct":12.6,"classes_total":3,"classes":[{"class":"Azole Antifungal","setting":"prescribed","share_pct":9.7,"drugs":[{"name":"Ketoconazole","share_pct":100}],"max_beneficiaries":54},{"class":"Tetracycline-class Drug","setting":"prescribed","share_pct":1.5,"drugs":[{"name":"Doxycycline Hyclate","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2023,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":7,"fiscal_years":{"first":1998,"last":2022},"rows_total":50,"shown":3,"withheld":47,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R44MH122109","title":"Teaching attentional awareness and control in ADHD","fiscal_year":2022,"amount_usd":"848175","organization":"THINK NOW, INC.","source_url":"https://reporter.nih.gov/quickSearch/R44MH122109"},{"project":"R44MH122109","title":"Teaching attentional awareness and control in ADHD","fiscal_year":2022,"amount_usd":"45000","organization":"THINK NOW, INC.","source_url":"https://reporter.nih.gov/quickSearch/R44MH122109"},{"project":"R44MH122109","title":"Teaching attentional awareness and control in ADHD","fiscal_year":2021,"amount_usd":"1087845","organization":"THINK NOW, INC.","source_url":"https://reporter.nih.gov/quickSearch/R44MH122109"}],"source":"grants"},"similar":[{"name":"Mark Ginsberg","slug":"mark-ginsberg","institution":"University of California System","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/mark-ginsberg","json_url":"https://www.findmykol.com/kol/mark-ginsberg/profile.json"},{"name":"Mark Mannis","slug":"mark-mannis","institution":"University of California System","specialty":"Specialist","url":"https://www.findmykol.com/kol/mark-mannis","json_url":"https://www.findmykol.com/kol/mark-mannis/profile.json"},{"name":"Lori Daniels","slug":"lori-daniels","institution":"University of California System","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/lori-daniels","json_url":"https://www.findmykol.com/kol/lori-daniels/profile.json"},{"name":"Jon Davids","slug":"jon-davids","institution":"University of California System","specialty":"Pediatric Orthopaedic Surgery","url":"https://www.findmykol.com/kol/jon-davids","json_url":"https://www.findmykol.com/kol/jon-davids/profile.json"},{"name":"Bridget Grant","slug":"bridget-grant","institution":"Bassett Medical Center","specialty":"Dermatology","url":"https://www.findmykol.com/kol/bridget-grant","json_url":"https://www.findmykol.com/kol/bridget-grant/profile.json"},{"name":"Robert Modlin","slug":"robert-modlin","institution":"University of California, Los Angeles","specialty":"Dermatology","url":"https://www.findmykol.com/kol/robert-modlin","json_url":"https://www.findmykol.com/kol/robert-modlin/profile.json"},{"name":"Andrew Blauvelt","slug":"andrew-blauvelt","institution":"University of Maryland School of Medicine","specialty":"Dermatology","url":"https://www.findmykol.com/kol/andrew-blauvelt","json_url":"https://www.findmykol.com/kol/andrew-blauvelt/profile.json"},{"name":"Howard Maibach","slug":"howard-maibach","institution":"University of California, San Francisco","specialty":"Dermatology","url":"https://www.findmykol.com/kol/howard-maibach","json_url":"https://www.findmykol.com/kol/howard-maibach/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":15,"funding":47}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}